Newron Pharmaceuticals SpA Aktie News & Pressemeldungen

Newron Pharmaceuticals SpA Eulerpool News

10.1.2025, 16:35:13

Newron und Myung In Pharm: Partnerschaft zur Entwicklung von Evenamide

Newron Pharmaceuticals SpA Aktie News

Newron Pharmaceuticals SpA wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Newron Pharmaceuticals SpA News stellen wir hier zusammen.

12. Mai ·
Yahoo
Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS)
24. März ·
Yahoo
Newron proposes renowned biopharma company founder and entrepreneur Dr. Chris Martin for election as Independent Chairman
9. Januar ·
Yahoo
Newron and Myung In Pharm Announce License Agreement for evenamide in South Korea
13. Dezember ·
Yahoo
Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories
8. August ·
Yahoo
Aligos Therapeutics Strengthens Board with Two New Independent Directors
18. Juni ·
Yahoo
Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City

Newron Pharmaceuticals SpA Aktie Pressemeldungen

Newron Pharmaceuticals SpA publiziert auf der Unternehmenswebseite regelmäßig Meldungen, die für Investoren relevant sind.

Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Für 2 € testen

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan